Patient 21 presented with a low‐grade primary tumor (Ki‐67 = 2%) and developed hepatic metastasis after his first line of treatment (Ki‐67 = 18%) and another hepatic metastasis after his second line of treatment (Ki‐67 = 40%). This evidence concerns the gene MKI67 and neoplasm.